• Russ B. Altman, M.D., Ph.D.

    Kenneth Fong Professor of Bioengineering, Genetics, Medicine, and by courtesy, of Computer Science
    Stanford University

  • David W. Bates, M.D., M.Sc.

    Senior Vice President for Quality and Safety, Brigham and Women’s Hospital
    Chief Quality Office, Brigham and Women’s Hospital
    Chief, Division of General Internal Medicine, Brigham and Women’s Hospital
    Co-Director, Program in Clinical Effectives, Harvard School of Public Health
    Medical Director, Clinical and Quality Analysis for Partners Healthcare
    Professor of Medicine, Harvard Medical School
    Professor of Health Policy and Management, Harvard School of Public Health

  • Kevin P. Campbell, Ph.D.

    Investigator, Howard Hughes Medical Institute
    Department Head, Molecular Physiology and Biophysics
    Roy J. and Lucille A. Carver Biomedical Research Chair, Molecular Physiology and Biophysics
    Professor, Neurology and Internal Medicine
    Director, Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center (MDCRC)

  • Thomas R. Cech

    Distinguished Professor, University of Colorado-Boulder
    Director, University of Colorado Biofrontiers Institute
    Investigator, Howard Hughes Medical Institute

  • Thomas O. Daniel, M.D.

    President of Research and Early Development, Celgene Corporation

  • J. William (Bill) Freytag, Ph.D.

    Former Chief Executive Officer, Myogen
    Managing Director, Freytag Holdings, LLC

  • Ann Graybiel, Ph.D.

    Institute Professor, Massachusetts Institute of Technology

  • William N. Hait, M.D., Ph.D.

    Global Head, Research and Development, Janssen, Pharmaceutical Companies of Johnson & Johnson

  • William G. Kaelin, Jr., M.D.

    Professor of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School
    Investigator, Howard Hughes Medical Institute
    Associate Director, Basic Science, Dana-Farber Cancer Institute/Harvard Cancer Center

  • Mark T. Keating, M.D.

    Vice President and Global Head of Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, Inc.

  • Titia de Lange, Ph.D.

    Leon Hess Professor, The Rockefeller University
    Director, Anderson Center for Cancer Research

  • Michael A. Marletta, Ph.D.

    CH and Annie Li Chair in the Molecular Biology of Diseases
    Department of Chemistry
    Department of Molecular and Cell Biology
    University of California, Berkeley

  • Olufunmilayo I Olopade, M.D., FACP, OON

    Walter L. Palmer Distinguished Service Professor, Departments of Medicine & Human Genetics
    Director, Center for Global Health, The University of Chicago

  • Neil R. Powe, M.D., M.P.H., M.B.A.

    Constance B. Wofsy Distinguished Professor of Medicine
    Vice-Chairman, Department of Medicine, University of California San Francisco
    Chief, Medical Services, San Francisco General Hospital
    Professor of Medicine, University of California San Francisco

  • Elliott Sigal, M.D., Ph.D.

    Former Executive Vice President, Chief Scientific Officer
    Bristol-Myers Squibb

  • Susan S. Taylor, Ph.D.

    Investigator, Howard Hughes Medical Institute
    Professor, Department of Chemistry & Biochemistry, Department of Pharmacology (University of California, San Diego)